{
    "relation": [
        [
            "Feature key",
            "Describes the effect of the experimental mutation of one or more amino acid(s) on the biological properties of the protein.More...Mutagenesisi",
            "Describes the effect of the experimental mutation of one or more amino acid(s) on the biological properties of the protein.More...Mutagenesisi",
            "Describes the effect of the experimental mutation of one or more amino acid(s) on the biological properties of the protein.More...Mutagenesisi",
            "Describes the effect of the experimental mutation of one or more amino acid(s) on the biological properties of the protein.More...Mutagenesisi",
            "Describes the effect of the experimental mutation of one or more amino acid(s) on the biological properties of the protein.More...Mutagenesisi",
            "Describes the effect of the experimental mutation of one or more amino acid(s) on the biological properties of the protein.More...Mutagenesisi",
            "Describes the effect of the experimental mutation of one or more amino acid(s) on the biological properties of the protein.More...Mutagenesisi",
            "Describes the effect of the experimental mutation of one or more amino acid(s) on the biological properties of the protein.More...Mutagenesisi"
        ],
        [
            "Position(s)",
            "14 \u2013 14",
            "14 \u2013 14",
            "17 \u2013 17",
            "49 \u2013 49",
            "197 \u2013 197",
            "197 \u2013 197",
            "199 \u2013 199",
            "199 \u2013 199"
        ],
        [
            "Length",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1"
        ],
        [
            "Description",
            "R \u2192 E: Reduces affinity for substrate about 7-fold, but has no effect on catalytic activity. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.9 \"Active site structure and stereospecificity of Escherichia coli pyridoxine-5'-phosphate oxidase.\" di Salvo M.L., Ko T.-P., Musayev F.N., Raboni S., Schirch V., Safo M.K. J. Mol. Biol. 315:385-397(2002) [PubMed] [Europe PMC] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (2.07 ANGSTROMS) IN COMPLEX WITH PYRIDOXAL 5'-PHOSPHATE AND FMN, SUBUNIT, BIOPHYSICOCHEMICAL PROPERTIES, MUTAGENESIS OF ARG-14; TYR-17; ASP-49; ARG-197 AND HIS-199.",
            "R \u2192 M: Reduces affinity for substrate about 9-fold, but has no effect on catalytic activity. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.9 \"Active site structure and stereospecificity of Escherichia coli pyridoxine-5'-phosphate oxidase.\" di Salvo M.L., Ko T.-P., Musayev F.N., Raboni S., Schirch V., Safo M.K. J. Mol. Biol. 315:385-397(2002) [PubMed] [Europe PMC] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (2.07 ANGSTROMS) IN COMPLEX WITH PYRIDOXAL 5'-PHOSPHATE AND FMN, SUBUNIT, BIOPHYSICOCHEMICAL PROPERTIES, MUTAGENESIS OF ARG-14; TYR-17; ASP-49; ARG-197 AND HIS-199.",
            "Y \u2192 F: Reduces affinity for substrate 3-fold, but has about 5-fold increase in catalytic activity. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.9 \"Active site structure and stereospecificity of Escherichia coli pyridoxine-5'-phosphate oxidase.\" di Salvo M.L., Ko T.-P., Musayev F.N., Raboni S., Schirch V., Safo M.K. J. Mol. Biol. 315:385-397(2002) [PubMed] [Europe PMC] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (2.07 ANGSTROMS) IN COMPLEX WITH PYRIDOXAL 5'-PHOSPHATE AND FMN, SUBUNIT, BIOPHYSICOCHEMICAL PROPERTIES, MUTAGENESIS OF ARG-14; TYR-17; ASP-49; ARG-197 AND HIS-199.",
            "D \u2192 A: Reduces affinity for substrate 3-fold and catalytic activity 2-fold. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.9 \"Active site structure and stereospecificity of Escherichia coli pyridoxine-5'-phosphate oxidase.\" di Salvo M.L., Ko T.-P., Musayev F.N., Raboni S., Schirch V., Safo M.K. J. Mol. Biol. 315:385-397(2002) [PubMed] [Europe PMC] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (2.07 ANGSTROMS) IN COMPLEX WITH PYRIDOXAL 5'-PHOSPHATE AND FMN, SUBUNIT, BIOPHYSICOCHEMICAL PROPERTIES, MUTAGENESIS OF ARG-14; TYR-17; ASP-49; ARG-197 AND HIS-199.",
            "R \u2192 E: Reduces affinity for substrate 8000-fold and catalytic activity 16-fold. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.9 \"Active site structure and stereospecificity of Escherichia coli pyridoxine-5'-phosphate oxidase.\" di Salvo M.L., Ko T.-P., Musayev F.N., Raboni S., Schirch V., Safo M.K. J. Mol. Biol. 315:385-397(2002) [PubMed] [Europe PMC] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (2.07 ANGSTROMS) IN COMPLEX WITH PYRIDOXAL 5'-PHOSPHATE AND FMN, SUBUNIT, BIOPHYSICOCHEMICAL PROPERTIES, MUTAGENESIS OF ARG-14; TYR-17; ASP-49; ARG-197 AND HIS-199.",
            "R \u2192 M: Reduces affinity for substrate 300-fold and catalytic activity about 4-fold. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.9 \"Active site structure and stereospecificity of Escherichia coli pyridoxine-5'-phosphate oxidase.\" di Salvo M.L., Ko T.-P., Musayev F.N., Raboni S., Schirch V., Safo M.K. J. Mol. Biol. 315:385-397(2002) [PubMed] [Europe PMC] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (2.07 ANGSTROMS) IN COMPLEX WITH PYRIDOXAL 5'-PHOSPHATE AND FMN, SUBUNIT, BIOPHYSICOCHEMICAL PROPERTIES, MUTAGENESIS OF ARG-14; TYR-17; ASP-49; ARG-197 AND HIS-199.",
            "H \u2192 A: Reduces affinity for substrate 230-fold, but has no effect on catalytic activity. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.9 \"Active site structure and stereospecificity of Escherichia coli pyridoxine-5'-phosphate oxidase.\" di Salvo M.L., Ko T.-P., Musayev F.N., Raboni S., Schirch V., Safo M.K. J. Mol. Biol. 315:385-397(2002) [PubMed] [Europe PMC] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (2.07 ANGSTROMS) IN COMPLEX WITH PYRIDOXAL 5'-PHOSPHATE AND FMN, SUBUNIT, BIOPHYSICOCHEMICAL PROPERTIES, MUTAGENESIS OF ARG-14; TYR-17; ASP-49; ARG-197 AND HIS-199.",
            "H \u2192 N: Reduces catalytic activity about 4-fold, but has no effect on affinity for substrate. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.9 \"Active site structure and stereospecificity of Escherichia coli pyridoxine-5'-phosphate oxidase.\" di Salvo M.L., Ko T.-P., Musayev F.N., Raboni S., Schirch V., Safo M.K. J. Mol. Biol. 315:385-397(2002) [PubMed] [Europe PMC] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (2.07 ANGSTROMS) IN COMPLEX WITH PYRIDOXAL 5'-PHOSPHATE AND FMN, SUBUNIT, BIOPHYSICOCHEMICAL PROPERTIES, MUTAGENESIS OF ARG-14; TYR-17; ASP-49; ARG-197 AND HIS-199."
        ],
        [
            "Graphical view",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            ""
        ],
        [
            "Feature identifier",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            ""
        ],
        [
            "Actions",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            ""
        ]
    ],
    "pageTitle": "pdxH - Pyridoxine/pyridoxamine 5'-phosphate oxidase - Escherichia coli (strain K12)",
    "title": "",
    "url": "http://www.uniprot.org/uniprot/P0AFI7",
    "hasHeader": true,
    "headerPosition": "FIRST_ROW",
    "tableType": "RELATION",
    "tableNum": 5,
    "s3Link": "common-crawl/crawl-data/CC-MAIN-2015-32/segments/1438042988458.74/warc/CC-MAIN-20150728002308-00086-ip-10-236-191-2.ec2.internal.warc.gz",
    "recordEndOffset": 801521643,
    "recordOffset": 801483914,
    "tableOrientation": "HORIZONTAL",
    "lastModified": "Wed, 22 Jul 2015 00:00:00 GMT",
    "textBeforeTable": "Mutagenesis <p>Provides information on the disease(s) and phenotype(s) associated with the deficiency of a protein.</p><p><a href='../manual/pathology_and_biotech_section' target='_top'>More...</a></p>Pathology & Biotechi EG11487. pdxH. Escherichia coli strain K12 genome database<br/><a href='/database/21'>More..</a>EcoGenei Organism-specific databases UP000000318 <p>A UniProt <a href=\"/manual/proteomes_manual\">proteome</a> can consist of several components. <br />The component name refers to the genomic component encoding a set of proteins. <br />These range from a single component such as Viral genomes to several components as in the case of eukaryotic chromosomes. They may also represent different stages in a genome project and include components such as contigs, scaffolds or Whole Genome Shotgun (WGS) master records.</p><p><a href='../manual/proteome_component' target='_top'>More...</a></p> Componenti: Chromosome UP000000625 <p>A UniProt <a href=\"/manual/proteomes_manual\">proteome</a> can consist of several components. <br />The component name refers to the genomic component encoding a set of proteins. <br />These range from a single component such as Viral genomes to several components as in the case of eukaryotic chromosomes. They may also represent different stages in a genome project and include components such as contigs, scaffolds or Whole Genome Shotgun (WGS) master records.</p><p><a href='../manual/proteome_component' target='_top'>More...</a></p> Componenti: Chromosome <p>Is present for entries that are part of a <a href=\"/proteomes\">proteome</a>, i.e. of a set of proteins thought to be expressed by organisms whose",
    "textAfterTable": "<p>Describes post-translational modifications (PTMs) and/or processing events.</p><p><a href='../manual/ptm_processing_section' target='_top'>More...</a></p>PTM / Processingi Molecule processing Feature key Position(s) Length Description Graphical view Feature identifier Actions <p>Indicates that the initiator methionine is cleaved from the mature protein.</p><p><a href='../manual/init_met' target='_top'>More...</a></p>Initiator methioninei 1\u00a0\u2013\u00a01 1 Removed1 Publication <p>Manually curated information for which there is published experimental evidence.</p> <p><a href=\"/manual/evidences#ECO:0000269\">More\u2026</a></p> Manual assertion based on experiment ini Ref.5 \"Kinetic limitation and cellular amount of pyridoxine (pyridoxamine) 5'-phosphate oxidase of Escherichia coli K-12.\" Zhao G., Winkler M.E. J. Bacteriol. 177:883-891(1995) [ PubMed] [ Europe PMC] [ Abstract] Cited for: PROTEIN SEQUENCE OF 2-11, CHARACTERIZATION. <p>Describes the extent of a polypeptide chain in the mature protein following processing.</p><p><a href='../manual/chain' target='_top'>More...</a></p>Chaini 2\u00a0\u2013\u00a0218 217 Pyridoxine/pyridoxamine 5'-phosphate oxidase",
    "hasKeyColumn": false,
    "keyColumnIndex": -1,
    "headerRowIndex": 0
}